![Capecitabine and Docetaxel Combination for the Treatment of Breast Cancer - Mariko Morishita, Robert C Leonard, 2008 Capecitabine and Docetaxel Combination for the Treatment of Breast Cancer - Mariko Morishita, Robert C Leonard, 2008](https://journals.sagepub.com/cms/10.2217/17455057.4.1.11/asset/images/large/10.2217_17455057.4.1.11-fig1.jpeg)
Capecitabine and Docetaxel Combination for the Treatment of Breast Cancer - Mariko Morishita, Robert C Leonard, 2008
![PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e7d901374eddb6500e1e3f83e8039d512de691b3/5-Table2-1.png)
PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar
![Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/abc9c9cb28e5293cdf9a9687c3a5a9f40dfb7897-427x220.gif?fit=crop&auto=format)
Lower Dose Capecitabine Is Active and Has Favorable Safety Profile in Elderly Patients With Advanced Breast Cancer
Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
![Capecitabine as Salvage Therapy for a Pancreatic Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function Capecitabine as Salvage Therapy for a Pancreatic Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function](https://www.primescholars.com/articles-images/pancreas-9-3-3-t001.png)
Capecitabine as Salvage Therapy for a Pancreatic Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function
![PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e7d901374eddb6500e1e3f83e8039d512de691b3/2-Table1-1.png)
PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar
![Cancers | Free Full-Text | Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214 Cancers | Free Full-Text | Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214](https://pub.mdpi-res.com/cancers/cancers-13-04399/article_deploy/html/images/cancers-13-04399-g001.png?1631173245)
Cancers | Free Full-Text | Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214
![Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial | Trials | Full Text Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-015-0753-7/MediaObjects/13063_2015_753_Fig1_HTML.gif)
Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial | Trials | Full Text
![P-121 Phase Ib trial of oxaliplatin, UGT1A1 genotype-directed dosing of irinotecan and chronomodulated capecitabine (OXIRI) chemotherapy in patients with advanced pancreatic cancer - Annals of Oncology P-121 Phase Ib trial of oxaliplatin, UGT1A1 genotype-directed dosing of irinotecan and chronomodulated capecitabine (OXIRI) chemotherapy in patients with advanced pancreatic cancer - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/7b2ec333-e42f-4a7e-9488-8fd8e70c919b/fx1.jpg)